On January 3, 2020, the 2020 China (Guangdong) Cardiovascular Industry Innovation and Transformation Summit Forum was held in Zhuhai. Several cardiovascular experts and hundreds of professionals from related industries at home and abroad exchanged and discussed how to promote the development of high-end interventional consumables and cardiovascular medical devices industry.
On that day, the Hong Kong Asian Heart Center and Guangdong Pulse Medical Technology Co., Ltd. signed a strategic cooperation agreement for the Guangdong Hong Kong Cardiovascular Industry Innovation and Transformation Research and Development Center to help Zhuhai deeply promote cardiovascular clinical research and the innovative transformation of related achievements. On the same day, the Guangdong branch of the China Cardiovascular Innovation Club (CCI) was also established. At the sub forum, dozens of medical innovation enterprises from all over the country conducted on-site roadshows.
According to Ruan Chengmin, Chairman of Guangdong Pulse Medical Co., Ltd., in recent years, cardiovascular intervention therapy devices have become a globally concentrated research and development field, and cardiovascular intervention therapy has also become one of the three modern medical treatment methods, alongside traditional internal medicine drug therapy and surgical treatment. At present, China's cardiovascular intervention medical technology is gradually keeping pace with the world, and more and more cutting-edge medical technologies are being referenced and developed in China. The future of cardiovascular medical technology in China is worth looking forward to.
Data shows that currently, there are as many as 15 million deaths worldwide each year due to cardiovascular and cerebrovascular diseases. The 2016 China Cardiovascular Disease Report also shows that the incidence of cardiovascular disease in China is also on the rise, with the current number of cardiovascular disease patients exceeding one-fifth of the total population. As a result, multiple experts have pointed out that the prevention and treatment of cardiovascular and cerebrovascular diseases is a long and arduous task. It is not only a part of treating diseases, but also involves the prevention, treatment, and rehabilitation of the entire life cycle.
It is reported that the development of China's cardiovascular interventional therapy equipment industry is showing three major trends: firstly, import substitution is the trend, but it is not simply imitation, but starting from clinical practice to provide better products; Secondly, the future market for cardiovascular and cerebrovascular services will be at the grassroots level, and the business model will continue to change; Thirdly, there is an increasing integration of industries, and innovation knows no boundaries; Thirdly, large chain institutions may emerge in the field of cardiovascular and cerebrovascular diseases.